Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Cancer Research
|
March 17, 2006
Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylation
Takahiko Kobayashi, Ting Wang, Masaji Maezawa, et al.
Hepatology Communications
|
February 7, 2018
Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease
Yohei Masugi, Tokiya Abe, Hanako Tsujikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 28, 2012
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients
Hiroaki Saito, Kiyoaki Ito, Masaya Sugiyama, et al.
Journal of Gastroenterology
|
June 26, 2009
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
Makoto Chuma, Shuhei Hige, Toshiya Kamiyama, et al.
Hepatology International
|
August 12, 2009
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan
Yoshiaki Iwasaki, Yasushi Shiratori, Shuhei Hige, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 19, 2011
Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial
Kentaro Matsuura, Yasuhito Tanaka, Atsunori Kusakabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 14, 2004
Hepatitis B virus genotype G is an extremely rare genotype in Japan
Hideaki Kato, Fuminaka Sugauchi, Atsushi Ozasa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 26, 2022
Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study
Tatsunori Hanai, Hideto Kawaratani, Junji Nagano, et al.
Journal of Clinical Microbiology
|
March 11, 2011
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B
Kiyoaki Ito, Katsuya Higami, Naohiko Masaki, et al.
Journal of Gastroenterology and Hepatology
|
April 20, 2011
Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation
Makoto Chuma, Hiroshi Taguchi, Yoshiya Yamamoto, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Cancer Research
|
March 17, 2006
Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylation
Takahiko Kobayashi, Ting Wang, Masaji Maezawa, et al.
Hepatology Communications
|
February 7, 2018
Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease
Yohei Masugi, Tokiya Abe, Hanako Tsujikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 28, 2012
Factors responsible for the discrepancy between IL28B polymorphism prediction and the viral response to peginterferon plus ribavirin therapy in Japanese chronic hepatitis C patients
Hiroaki Saito, Kiyoaki Ito, Masaya Sugiyama, et al.
Journal of Gastroenterology
|
June 26, 2009
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
Makoto Chuma, Shuhei Hige, Toshiya Kamiyama, et al.
Hepatology International
|
August 12, 2009
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan
Yoshiaki Iwasaki, Yasushi Shiratori, Shuhei Hige, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 19, 2011
Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial
Kentaro Matsuura, Yasuhito Tanaka, Atsunori Kusakabe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 14, 2004
Hepatitis B virus genotype G is an extremely rare genotype in Japan
Hideaki Kato, Fuminaka Sugauchi, Atsushi Ozasa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 26, 2022
Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study
Tatsunori Hanai, Hideto Kawaratani, Junji Nagano, et al.
Journal of Clinical Microbiology
|
March 11, 2011
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B
Kiyoaki Ito, Katsuya Higami, Naohiko Masaki, et al.
Journal of Gastroenterology and Hepatology
|
April 20, 2011
Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation
Makoto Chuma, Hiroshi Taguchi, Yoshiya Yamamoto, et al.
Page
of 8